Value through Innovation24 July 2014

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

03.06.2014

Boehringer Ingelheim Announces Successful Resolution of FDA Warning Letter

02.06.2014

New data show Giotrif® (afatinib) provided more than one year additional survival for lung cancer patients with the most common type of EGFR mutation (del19) compared to chemotherapy

- For Ex-US and Ex-UK Media Only
30.05.2014

ASCO 2014: Boehringer Ingelheim to present latest oncology research, including overall survival results for Giotrif® (afatinib) in advanced NSCLC

- For Ex-US and Ex-UK Media Only
28.05.2014

Boehringer Ingelheim announces comprehensive settlement of U.S. Pradaxa® (dabigatran etexilate) litigation

23.05.2014

Type 2 Diabetes: European Commission approves Jardiance® (empagliflozin)

- For Non-U.S. and Non-U.K. Media
22.05.2014

Antidote for rapid reversal of Pradaxa® (dabigatran etexilate) progresses into next stage of clinical investigation with study in patients

- For media outside of the U.S., the UK & Canada only
21.05.2014

ATS 2014
COPD: First Phase III data show lung function benefits of tiotropium + olodaterol fixed-dose combination go beyond tiotropium (Spiriva®) alone

- For media outside UK, U.S. and Canada
19.05.2014

Additional results from post-hoc analysis underline effectiveness of SPIRIVA®

- For ex-US and ex-UK Media Use Only  
18.05.2014

IPF Phase III results published in NEJM show nintedanib* slows disease progression

- For non-US health media only
15.05.2014

As the benefits and safety of Pradaxa® (dabigatran etexilate) are once again confirmed, Boehringer Ingelheim continues to look for new ways for Pradaxa® to help more patients

- For media outside of the U.S., the UK & Canada only
15.05.2014

New analysis shows Boehringer Ingelheim’s Giotrif® (afatinib) is the first treatment to demonstrate significant overall survival benefit for patients with a specific type of lung cancer

- For Ex-US and Ex-UK Media Only
12.05.2014

Boehringer Ingelheim will make detailed clinical trial data available to the scientific community

07.05.2014

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

- For media outside of the U.S., the UK & Canada only
07.05.2014

New registry data highlight substantial global differences in stroke prevention for patients with an irregular heart beat

- For media outside of the U.S., the UK & Canada only
06.05.2014

Type 2 Diabetes Research: Connexios Life Sciences and Boehringer Ingelheim Enter Agreement for Novel AMPK Activators

30.04.2014

Boehringer Ingelheim Animal Health announces the 2014 European PRRS Research Award

30.04.2014

Boehringer Ingelheim to present highly anticipated Phase III data in IPF and COPD at ATS International Conference

- For media outside UK, U.S. and Canada
25.04.2014

Positive CHMP opinion for Pradaxa® in treatment of deep vein thrombosis and pulmonary embolism and prevention of repeat blood clots

- For media outside of the U.S., the UK & Canada only